It is a privilege to serve as the founding Director of the Blau Center for Precision Medicine and Translational Research. For more than a decade, my research has focused on understanding how NOD2 mutations drive inflammatory diseases, with a particular emphasis on Blau syndrome. By partnering closely with clinicians, patients, and families, we have translated these discoveries into targeted therapies that are already improving patient care while helping shape the future of precision medicine.